Key Insights

Highlights

Success Rate

86% trial completion

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 52/100

Termination Rate

6.6%

5 terminated out of 76 trials

Success Rate

85.7%

-0.8% vs benchmark

Late-Stage Pipeline

12%

9 trials in Phase 3/4

Results Transparency

27%

8 of 30 completed with results

Key Signals

8 with results86% success

Data Visualizations

Phase Distribution

54Total
Not Applicable (33)
Early P 1 (1)
P 1 (5)
P 2 (6)
P 3 (2)
P 4 (7)

Trial Status

Completed30
Recruiting16
Unknown10
Not Yet Recruiting7
Terminated5
Active Not Recruiting2

Trial Success Rate

85.7%

Benchmark: 86.5%

Based on 30 completed trials

Clinical Trials (76)

Showing 20 of 20 trials
NCT07143019Not ApplicableRecruitingPrimary

The Use of p48/64 MW HPC Flow Modulation Device in the Treatment of Wide-necked Intracranial Aneurysms

NCT06999122Recruiting

Diagnostic Performance Study of the EMVision Emu™ Brain Scanner in the Detection of Intracranial Hemorrhage in Suspected Stroke Patients

NCT07649135Not ApplicableRecruiting

Feasibility of a Remotely Delivered Step Count Intervention in Chronic Stroke

NCT04975646Not ApplicableRecruiting

Goal Attainment Scaling in Upper Limb Spasticity Treatment

NCT04534556Not ApplicableEnrolling By Invitation

Wireless Nerve Stimulation Device To Enhance Recovery After Stroke

NCT07627399Not ApplicableRecruiting

Effectiveness of Best Care Practices in Acute Stroke in Conventional Hospitalization (BEST CARE ICTUS_HC)

NCT06094478Not ApplicableRecruiting

Hospital Implementation of a Stroke Protocol for Emergency Evaluation and Disposition

NCT04427241Phase 4Recruiting

Efficacy and Safety of Cerebrolysin on Prolonged Disorders of Consciousness

NCT05113043Recruiting

Correlation Between Intestinal Microecology Imbalance and Stroke in Young Adults

NCT05128513Not ApplicableSuspendedPrimary

Delipid Extracorporeal Lipoprotein Filter From Plasma (DELP) for Acute Hemorrhagic Stroke

NCT06308952Phase 4Recruiting

Atorvastatin Pretreatment in Cerebrovascular Events (APICES) After Flow Diverter Implantation

NCT05397106Active Not Recruiting

Post Market Clinical Follow-up of CODMAN CERTAS Programmable Valve

NCT07433972Not ApplicableNot Yet RecruitingPrimary

Changes in Hemodynamic Response Following Transcranial Electrical Stimulation in Sroke Individuals

NCT06134921Not ApplicableCompleted

Effects of Transcranial Electrical Stimulation in Stroke Individuals

NCT07236216Not ApplicableRecruitingPrimary

Effects of tES Combined With CMDT Gait Training on Cognition, Cortical Activity, Spinal Motoneuron Excitability and Motor Performance in Stroke Individuals

NCT06679803Not ApplicableEnrolling By Invitation

Feasibility of a First-Line Physical Activity Intervention After Stroke

NCT04279067Not ApplicableCompleted

BCI-FES Therapy for Stroke Rehabilitation

NCT07353749Phase 4Not Yet Recruiting

Efficacy and Safety of Methylprednisolone After Flow-Diverter Stent Implantation in Unruptured Intracranial Aneurysms

NCT06069973Recruiting

Using Machine Learning and Biomarkers for Early Detection of Delayed Cerebral Ischemia

NCT07224178Recruiting

Left Atrial Strain and Cryptogenic Stroke

Scroll to load more

Research Network

Activity Timeline